Navigation Links
Clinilabs Opens Phase I Unit In Eatontown, New Jersey
Date:5/28/2012

NEW YORK, May 28, 2012 /PRNewswire-iReach/ -- Clinilabs, an early phase and specialty CRO that provides clinical drug development services to the pharmaceutical industry, today announced that they have opened a second Phase I unit in Southern New Jersey.  The 50-bed capacity, 15,000 square foot Specialty Pharma Phase I Unit features semi private rooms, a large PK sampling facility, a bioanalytic laboratory, pharmacy, and exam rooms.

Since 2001, Clinilabs has successfully completed clinical trials involving healthy, adult human volunteers and specialty patient populations.  The staff has accrued experience in over 800 clinical studies, offering clients the service capacity of a big CRO – delivered by an organization that is right-sized and priced for early phase projects.  The opening of the New Jersey Specialty Pharma Phase I Unit expands services currently offered at the company's 50 bed, state-of-the-art, Phase I unit in Manhattan, raising total bed capacity to 100.

"I am pleased to announce the opening of our new unit in Eatontown, New Jersey", states Dr. Gary Zammit.  "This unit allows us to expand our Phase I capacity in two locations, providing first-in-human through end-of-phase II CRO services to our clients.  We are now able to enroll larger samples of normal healthy volunteers and patient populations at our two units and at investigator sites worldwide."

About Clinilabs Inc.

Clinilabs is a contract research organization (CRO) that provides early-phase and specialty clinical drug development services to industry. We offer teams, processes, and technology solutions that are designed to serve single center and multicenter early-phase studies – services that can be scaled as needed to meet the requirements of any clinical development program. For more information, please visit www.clinilabs.com.

Media Contact: Hannah DAoust Clinilabs, 646-215-6480, hdaoust@clinilabs.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE Clinilabs
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
2. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
3. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
4. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
5. PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal
6. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
7. Medpace Opens Clinical Pharmacology Unit in Cincinnati, Ohio
8. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
9. EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations
10. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
11. CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2020)... ... August 27, 2020 , ... Bridge To A Cure Foundation announces ... an adult and pediatric neuro-oncologist who serves on the Board of Directors at The ... Duke University Medical School. , Internationally recognized, Dr. Friedman is a widely published author ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... purification systems kill Coronavirus. While air purification technologies, including GreenTech Environmental’s proprietary methods, ... even Ebola, no air purification system has published results of singular and scientific ...
(Date:8/26/2020)... ... 26, 2020 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through education programs, outreach initiatives and patient services ... and Charity Auction on Wednesday, Sept. 30 . The “Finding Cures Starts ...
Breaking Medicine Technology:
(Date:9/3/2020)... ... 03, 2020 , ... International Dark-Sky Association (IDA) recently bestowed ... controller. This advanced LED wireless dimming controller, along with the previously IDA approved ... sky against light pollution. Leo Smith, the Northeast Regional Director for IDA says ...
(Date:9/1/2020)... ... ... Feeding Matters , the first organization in the world dedicated to advancing ... announce that the U.S. Centers for Disease Control and Prevention (CDC) has officially approved ... the U.S. International Classification of Diseases (ICD ) on October 1, 2021. ...
(Date:8/31/2020)... ... August 31, 2020 , ... The Lymphoma Research Foundation ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... Blood Cancer Awareness Month (BCAM) and its international Light it Red for ...
(Date:8/31/2020)... ... 31, 2020 , ... Genesis Chiropractic Software and Billing ... launch of its integrated, HIPAA compliant, telehealth solution, available to US-based clients immediately. ... 90 seconds. , According to the U.S. Department of Health & Human ...
(Date:8/31/2020)... ... 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis , At ... a state of panic, experiencing deep anxiety, immense stress, and right now are needing serious ... when most people on the planet are experiencing a great degree of emotional discomfort, be ...
Breaking Medicine News(10 mins):